Patient Experiences in Selecting a Medicare Part D Prescription Drug Plan

被引:14
|
作者
Stults, Cheryl D. [1 ]
Baskin, Alison S. [2 ]
Bundorf, M. Kate [3 ]
Tai-Seale, Ming [1 ,4 ]
机构
[1] Palo Alto Med Fdn Res Inst, 2350 W El Camino Real,4th Floor, Mountain View, CA 94040 USA
[2] NIH, Bldg 10, Bethesda, MD 20892 USA
[3] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[4] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
来源
JOURNAL OF PATIENT EXPERIENCE | 2018年 / 5卷 / 02期
关键词
Medicare Part D; medical decision-making; qualitative methods; patient perspectives/narratives;
D O I
10.1177/2374373517739413
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Medicare beneficiaries often report that the process of choosing a prescription drug plan is frustrating and confusing and many do not enroll in the plan that covers their drugs at the lowest cost. Methods: We conducted 4 focus groups to understand beneficiaries' experiences in selecting a drug plan to identify what resources and factors were most important to them. Participants were patients served by a multispecialty delivery system and were primarily affluent and Caucasian. Results: While low cost was essential to many, other characteristics like having the same plan as a partner, company reputation, convenience, and anticipation of possible future health problems were sometimes more important. Although some used resources including insurance brokers, counselors, and websites beyond Medicare.gov, many expressed a desire for greater assistance with and greater simplicity in the choice process. Conclusion: Although older adults would likely benefit from greater assistance in choosing Medicare Part D prescription drug plans, more research is necessary to understand how to help with decision-making in this context.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [21] The new medicare part D prescription drug benefit: An estimation of its effect on prescription drug costs in a medicare population with atrial fibrillation
    Evans-Molina, Carmella
    Regan, Susan
    Henault, Lori E.
    Hylek, Elaine M.
    Schwartz, Gregory R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (07) : 1038 - 1043
  • [22] Medicare prescription drug plan costs and affordability - 2007
    Davis, Matthew M.
    Patel, Mitesh S.
    Halasyamani, Lakshmi K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (08) : 1221 - 1222
  • [23] Medicare Prescription Drug Plan Costs and Affordability—2007
    Matthew M. Davis
    Journal of General Internal Medicine, 2007, 22 : 1221 - 1222
  • [24] The relationship between plan characteristics and Medicare Prescription Drug Plan bids
    Dai, Rui
    Robst, John
    APPLIED ECONOMICS LETTERS, 2012, 19 (01) : 99 - 104
  • [25] Physicians' views regarding prescription drug access under medicare Part D
    Epstein, A. J.
    Rathore, S. S.
    Alexander, G. C.
    Ketcham, J. D.
    VALUE IN HEALTH, 2008, 11 (03) : A41 - A41
  • [26] Differential take-up of the medicare part D prescription drug benefit
    Rabbani, A.
    Yin, W.
    Zhang, J. X.
    Sun, S. X.
    Alexander, G. C.
    VALUE IN HEALTH, 2008, 11 (03) : A12 - A13
  • [27] THE EFFECT OF MEDICARE PART D PRESCRIPTION DRUG COVERAGE GAP ON MEDICATION ADHERENCE
    Said, Q.
    Li, C.
    Souder, E.
    Hastings, J. K.
    VALUE IN HEALTH, 2010, 13 (03) : A7 - A7
  • [28] Retirement Lock and Prescription Drug Insurance: Evidence from Medicare Part D
    Wettstein, Gal
    AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY, 2020, 12 (01) : 389 - 417
  • [29] Drug Plan Design Incentives Among Medicare Prescription Drug Plans
    Huskamp, Haiden A.
    Keating, Nancy L.
    Dalton, Jesse B.
    Chernew, Michael E.
    Newhouse, Joseph P.
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (07): : 562 - 568
  • [30] Differential take-up of the medicare part D prescription drug benefit
    Rabbani, A.
    Yin, W.
    Zhang, J. X.
    Sun, S.
    Alexander, G. C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 282 - 282